胎儿
化学
全氟辛酸
经胎盘
内科学
内分泌学
前脑
血红素
怀孕
代谢组
胆汁酸
羊水
胎盘
氧化物
代谢组学
新陈代谢
硝基酪氨酸
生物化学
氧化三甲胺
作者
Mengqi Zhang,Yawen Tian,Yitao Pan,Zhiwen Cheng,Jiayin Dai,Nan Sheng
标识
DOI:10.1021/acs.est.6c06687
摘要
Abstract Hexafluoropropylene oxide (HFPO)-based compounds have been increasingly adopted as replacements for legacy per- and polyfluoroalkyl substances (PFAS) such as perfluorooctanoic acid (PFOA), yet evidence on developmental toxicity remains limited. This study investigated structure-dependent maternal-fetal transfer, fetal tissue distribution, and hepatic effects of PFOA and four HFPO-based alternatives, including hexafluoropropylene oxide dimer acid (HFPO-DA) and hexafluoropropylene oxide trimer acid (HFPO-TA) homologues, in gestational mice. All compounds were detected in maternal serum, fetal tissues, and amniotic fluid in a dose-dependent manner, but transplacental transfer efficiencies varied markedly. C9 HFPO-TA showed the greatest fetal accumulation, indicating enhanced fetal retention. Desorption electrospray ionization mass spectrometry imaging revealed preferential hepatic localization of PFOA and HFPO trimers, with fetal hepatic burden increasing with van der Waals volume, suggesting structure-dependent enrichment. Metabolomics showed broad alterations of fetal hepatic metabolism, dominated by altered lipids and lipid-like molecules. 5-Aminolevulinic acid, a key heme precursor, was consistently reduced, whereas ALAS1 and ALAD protein levels increased, indicating perturbation of heme biosynthesis. The provisional, study-specific developmental reference doses derived from fetal or placental endpoints were comparable to or lower than those based on maternal hepatomegaly, suggesting greater developmental sensitivity. These findings reveal structure-dependent fetal liver accumulation and support incorporating fetal-specific endpoints into PFAS risk assessment.
科研通智能强力驱动
Strongly Powered by AbleSci AI